razoxane has been researched along with Emesis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cullinan, S; Everson, L; Gerstner, J; Krook, J; Laurie, J; McCormack, G; Schutt, A; Scott, M; Shreck, R; Windschitl, H | 1 |
| Basser, RL; Cebon, J; Duggan, G; Green, MD; Mihaly, G; Rosenthal, MA; Sobol, MM | 1 |
| Brion, N; Paule, B | 1 |
1 review(s) available for razoxane and Emesis
| Article | Year |
|---|---|
[Anticancer chemotherapy. Prevention of complications].
Topics: Antidotes; Antineoplastic Agents; Dose-Response Relationship, Drug; Glutathione; Heart; Humans; Iron Chelating Agents; Mesna; Neoplasms; Protective Agents; Razoxane; Vomiting | 1998 |
2 trial(s) available for razoxane and Emesis
| Article | Year |
|---|---|
Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Diarrhea; Drug Evaluation; Female; Fluorouracil; Humans; Leukopenia; Male; Middle Aged; Nausea; Random Allocation; Razoxane; Rectal Neoplasms; Semustine; Stomatitis; Thrombocytopenia; Triazines; Vomiting | 1983 |
Comparative study of the pharmacokinetics and toxicity of high-dose epirubicin with or without dexrazoxane in patients with advanced malignancy.
Topics: Adult; Aged; Drug Administration Schedule; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasms; Razoxane; Stomatitis; Vomiting | 1994 |